Xiao Jian-Hui, Qi Ying, Xiong Qing
Division of Applied Mycology and Biochemical Pharmacy, Key Laboratory of Cell Engineering of Guizhou Province, Affiliated Hospital of Zunyi Medical College, 149 Dalian Road, Zunyi 563000, China.
Recent Pat Biotechnol. 2013 Aug;7(2):153-66. doi: 10.2174/1872208311307020007.
Cordyceps, a well-known traditional Chinese medicine, is an endoparasitic and/or symbiotic macrofungus in the body of insect and other arthropod, and has received increasing attention worldwide due to its rarity and outstanding curative effects for different diseases. Recent years, however, the counterfeits and mimics of Cordyceps are frequently found in markets because of its scarce in nature and high in price. Therefore, quality control of Cordyceps and its bioproducts is very important to ensure their safety and efficacy. Nucleoside is recognized as a major active component of Cordyceps, and even is used as chemical marker for quality control of Cordyceps. In this present review, recent studies and associated patents, with regard to the chemical marker nucleosides for quality control of Cordyceps and its bioproducts, including nucleoside components, pharmacological activities, and analytical methods were reviewed and discussed thereof. Also, developing trends in the field have been appraised.
冬虫夏草是一种著名的中药材,是寄生于昆虫及其他节肢动物体内的内寄生和/或共生大型真菌,因其稀有性和对多种疾病显著的疗效而受到全球越来越多的关注。然而,近年来,由于冬虫夏草天然资源稀缺且价格高昂,市场上经常发现其假冒品和相似物。因此,冬虫夏草及其生物制品的质量控制对于确保其安全性和有效性非常重要。核苷被认为是冬虫夏草的主要活性成分,甚至被用作冬虫夏草质量控制的化学标志物。在本综述中,对近年来有关冬虫夏草及其生物制品质量控制化学标志物核苷的研究及相关专利进行了综述和讨论,包括核苷成分、药理活性及分析方法等,并对该领域的发展趋势进行了评估。